BOLD
BOLD
NASDAQ · Biotechnology

Boundless Bio Inc

$2.44
-0.02 (-0.81%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +399.6% upside
Low Target $8.12
Average Target $12.19
High Target $14.26
Current Price $2.44
Current
$2.44
Target
$12.19
$8.12 $12.19 avg $14.26
Scenario Analysis
Bear Case
$8.12
232.8%
Low target
Base Case
$12.19
+399.6%
Avg target
Bull Case
$14.26
+484.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.16
-22.9% from high
52-Week Low
$0.96
+153.8% from low
Target vs 52W High
$12.19
+285.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%